Evidence map›Paper›PMID 42196193›Full record

ArticleInternational journal of molecular sciences2026

Oleic Acid Levels in HSA

Dulce Peris-Moreno, Maria Sabater-Arcis, Nerea Moreno, Luis Orduña, Arturo López-Castel, Ariadna Bargiela, Ruben Artero

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dulce Peris-MorenoCIBERER ISCIII, Avenida Monforte de Lemos 3-5, 28029 Madrid, Spain.ORCID 0000-0001-6818-5900
Maria Sabater-ArcisCIBERER ISCIII, Avenida Monforte de Lemos 3-5, 28029 Madrid, Spain.
Nerea MorenoCIBERER ISCIII, Avenida Monforte de Lemos 3-5, 28029 Madrid, Spain.
Luis OrduñaINCLIVA Biomedical Research Institute, Avenida Menendez Pelayo 4, 46010 Valencia, Spain.ORCID 0000-0003-2756-4028
Arturo López-CastelCIBERER ISCIII, Avenida Monforte de Lemos 3-5, 28029 Madrid, Spain.ORCID 0000-0003-1529-2635
Ariadna BargielaCIBERER ISCIII, Avenida Monforte de Lemos 3-5, 28029 Madrid, Spain.ORCID 0000-0003-4336-2522
Ruben ArteroCIBERER ISCIII, Avenida Monforte de Lemos 3-5, 28029 Madrid, Spain.ORCID 0000-0003-1596-047X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myotonic dystrophy type 1 (DM1) is characterized by altered RNA processing, muscle wasting and metabolic dysregulation. In a previous in vitro study, we found reduced endogenous oleic acid (OA; 18:1n-9) in myogenic cells from DM1 patients, and short-term OA supplementation rescued key disease readouts. Here, we asked whether lipid pathways are perturbed in a DM1 in vivo background. We employed the widely used HSA

Indexed as

Myotonic DystrophyOleic AcidActinsAnimalsDisease Models, AnimalFemaleHumansLipid MetabolismMaleMiceMuscle, SkeletalActinsOleic Acidfatty acidsHSALRmyotonic dystrophy type 1 (DM1)oleic acidSdc1transcriptomics

Identifiers

PMID42196193
PMCPMC13206852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.